| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.22 | 0.08 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |